🔊 Important webinar on #AnticoagulationStewardship! Apr 30th: Update on Andexanet Alfa for Reversal of FXa Inhibitors: #Annexa-I Trial. Featuring JeanConnorsMD, Jori May, MD, Ashkan Shoamanesh, Deborah Siegal, & Jerrold Levy, MD Learn more and register: bit.ly/3vEmxLE

👢 We're 1 month out from our most popular in-person event! Join Geoff Barnes, Allison Burnett, Nate Clark, Bishoy Ragheb, Anita Rajasekhar, Andrea Van Beek & more for 2 days of personalized #Anticoagulation learning. Learn more and register: bit.ly/3vXac57

These findings underscore the complex role of IT testing in managing VTE, supporting personalized treatment strategies that consider VTE risk factors and comorbidities

The multi societal #PAD guideline in print at long last… Amazing things can happen when specialties work together, review the evidence, and put the patient at the center. Hats off to a most collaborative writing committee. Herb Aronow, MD, MPH (he/him/his) DartmouthSurgicalHSR Schuyler Jones

The prognostic value of blood cellular indices in acute PE Another #RIETEregistry manuscript

Congratulations fakiha and #RIETE

Sankey diagram on NLR in PE risk stratification from Supplement figs.

Really a great paper to read, call for and action! The strength of an international scientific Society ISTH

Thank you Joseph A Caprini for uploading this video on #VTE prevention. Endeavor Health #latinx

Elevated cellular indices are associated with increased mortality, highlighting their potential as prognostic markers These findings could enhance the precision of PE management strategies

Read this letter to the editor from Alex Spyropoulos discussing methodological concerns in the retrospective external validation of the IMPROVE score for VTE and bleeding Letter to the editor: rpthjournal.org/article/S2475-… Original paper: sciencedirect.com/science/articl…

#DYK that over 50% of VTE cases happen because of hospitalization 🏥? Were you or your loved one in the hospital when you experienced a clot? Let us know in the comments ⬇️ #WTDay24

¡Se acerca el día mundial de la trombosis! Utilice este kit para ayudarle a pensar en las diferentes formas en que puede utilizar las redes sociales para participar 📱 ¡Visite nuestro sitio web para obtener más recursos en español!

Great review on perioperative managent of DOAC treated patients by Dr Douketis and Alex Spyropoulos from JAMA

VTE recurrence after discontinuing anticoagulation in patients with VTE after receiving the vaccine against COVID-19 The #RIETEregistry experience appearing soon in EJCI

🔥Superb update on PE by Dr. Jay Giri today at OU Virtual CV GR 🔥Thanks Jay Giri for sharing your slides⬇️ ✅ Systemic thrombolysis is fraught with risk for ICH ✅ Catheter directed thrombolysis causes lower ICH risk ✅ Mechanical thrombectomy is superior ✅ ‘The Golden Era’

Phase 3 Oceanic AF with #FXIi asundexian a bust: clear inferiority to #DOAC for #stroke prevention. Lesson learned from Phase 2 data: get the dose and amount of #FXI inhibition right North American Thrombosis Forum Anticoagulation Forum Thrombosis UK Thrombosis Canada CanVECTOR Network

Need to 🤔 if ♀️♂️ differences in presentation, Tx, outcomes of #PE to do equitable care. First large study from China in Thrombosis Research #CURES: thrombosisresearch.com/article/S0049-… Editorial by McMaster University #DrBates & I: thrombosisresearch.com/article/S0049-… Connors Center for Women's Health & Gender Biology #thrombosis

I am excited and Humbled to be able to share with my community. Looking forward to discuss #Thrombosis #awareness. #latinx Endeavor Health John P Erwin III MD MBA FACC World Thrombosis Day

Did you know that direct oral anticoagulants (DOACs) are both the leading oral anticoagulant in use AND the leading cause of adverse drug events in US emergency departments?